STAT Plus: Gilead faces an antitrust complaint in Brazil over hepatitis C pricing
ERIC RISBERG/AP
Advocacy groups argue Gilead carried out "unlawful conduct" that "clearly affects the public interest,” because prices led the government to ration a drug.
.png)
No hay comentarios:
Publicar un comentario